Telomerase activity provides a mechanism for the unlimited division potential of neoplastic cells. Induced differentiation of these cells was found to be associated with repression of telomerase activity irrespective of the inducing agent. We have employed a series of sublines of human promyelocytic
β¦ LIBER β¦
Arsenic trioxide downregulates telomerase activity in HL-60 cells
β Scribed by Dong-mei He; Huan Zhang
- Publisher
- Chinese Anti-Cancer Association
- Year
- 2002
- Tongue
- English
- Weight
- 607 KB
- Volume
- 14
- Category
- Article
- ISSN
- 1000-9604
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Downregulation of telomerase activity in
β
Trevor W. Reichman; Juan Albanell; Xuening Wang; Malcolm A.S. Moore; George P. S
π
Article
π
1997
π
John Wiley and Sons
π
English
β 383 KB
π 2 views
The enhancement of sensitivity of HL-60
β
Haiyan Hu; Yuan Zhang; Dongmei He
π
Article
π
2007
π
Springer
π
English
β 264 KB
Inhibition of telomerase activity during
β
Xiao-shan Liu; Ling-sheng Lou; Ji-kai Jiang; Bei-zhong Liu; Jian-fang Zhou; Zong
π
Article
π
1999
π
Chinese Anti-Cancer Association
π
English
β 209 KB
Effect of arsenic trioxide or ATRA on pr
β
Guo-sheng Jiang; Tian-hua Tang; Guan-lin Sun; Yu-kun Zhang; Wei-li Wu; Liang-yu
π
Article
π
2001
π
Chinese Anti-Cancer Association
π
English
β 357 KB
Curcumin-induced apoptosis in human leuk
β
Sutapa Mukherjee (nee Chakraborty); Utpal Ghosh; N. P. Bhattacharyya; R. K. Bhat
π
Article
π
2006
π
Springer
π
English
β 299 KB
Role of Myc in differentiation and apopt
β
Guosheng Jiang; Ami Albihn; Tianhua Tang; Zhigang Tian; Marie Henriksson
π
Article
π
2008
π
Elsevier Science
π
English
β 987 KB
Acute promyelocytic leukemia (APL) is highly malignant and frequently expresses the PML-RARβ£ (promyelocytic leukemia-retinoic acid receptor-β£) fusion protein. This fusion protein is targeted by all-trans retinoic acid (ATRA) and arsenic trioxide (As 2 O 3 ), presently used in APL therapy. We have ev